Emerging evidence suggests that cancer stem-like cell populations, characterized by markers such as CD44 and Protein kinase D1 (PKD1), contribute to intratumoral heterogeneity and tumor maintenance in PanNETs. This evidence concerns the gene CD44 and cancer.